References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015). DOCK 6: Impact of new features and current docking performance. Journal of Computational Chemistry, 36(15), 1132–1156. https://doi.org/https://doi.org/10.1002/jcc.23905
- Baker, N. A., Sept, D., Joseph, S., Holst, M. J., & McCammon, J. A. (2001). Electrostatics of nanosystems: Application to microtubules and the ribosome. Proceedings of the National Academy of Sciences of the United States of America, 98(18), 10037–10041. https://doi.org/https://doi.org/10.1073/pnas.181342398
- Buchoux, S. (2017). FATSLiM: A fast and robust software to analyze MD simulations of membranes. Bioinformatics (Oxford, England), 33(1), 133–134. https://doi.org/https://doi.org/10.1093/bioinformatics/btw563
- Carmeliet, E. (1992). Voltage- and time-dependent block of the delayed K + current in cardiac myocytes by dofetilide. The Journal of Pharmacology and Experimental Therapeutics, 262(2), 809–817.
- Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002). Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K(+) channel blockers. Journal of Medicinal Chemistry, 45(18), 3844–3853. https://doi.org/https://doi.org/10.1021/jm0208875
- Ceccarini, L., Masetti, M., Cavalli, A., & Recanatini, M. (2012). Ion conduction through the hERG potassium channel. PLoS One, 7(11), e49017. https://doi.org/https://doi.org/10.1371/journal.pone.0049017
- Chen, J., Seebohm, G., & Sanguinetti, M. C. (2002). Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels. Proceedings of the National Academy of Sciences of the United States of America, 99(19), 12461–12466. https://doi.org/https://doi.org/10.1073/pnas.192367299
- Chen, X., Wang, Q., Ni, F., & Ma, J. (2010). Structure of the full-length Shaker potassium channel Kv1.2 by normal-mode-based X-ray crystallographic refinement. Proceedings of the National Academy of Sciences of the United States of America, 107(25), 11352–11357. https://doi.org/https://doi.org/10.1073/pnas.1000142107
- Clayton, G. M., Altieri, S., Heginbotham, L., Unger, V. M., & Morais-Cabral, J. H. (2008). Structure of the transmembrane regions of a bacterial cyclic nucleotide-regulated channel. Proceedings of the National Academy of Sciences of the United States of America, 105(5), 1511–1515. https://doi.org/https://doi.org/10.1073/pnas.0711533105
- Colenso, C. K., Sessions, R. B., Zhang, Y. H., Hancox, J. C., & Dempsey, C. E. (2013). Interactions between voltage sensor and pore domains in a hERG K + channel model from molecular simulations and the effects of a voltage sensor mutation. Journal of Chemical Information and Modeling, 53(6), 1358–1370. https://doi.org/https://doi.org/10.1021/ci4000739
- Dahl, A. C., Chavent, M., & Sansom, M. S. (2012). Bendix: Intuitive helix geometry analysis and abstraction. Bioinformatics (Oxford, England), 28(16), 2193–2194. https://doi.org/https://doi.org/10.1093/bioinformatics/bts357
- de la Peña, P., Machín, A., Fernández-Trillo, J., Domínguez, P., & Barros, F. (2013). Mapping of interactions between the N- and C-termini and the channel core in HERG K + channels. The Biochemical Journal, 451(3), 463–474. https://doi.org/https://doi.org/10.1042/BJ20121717
- Dempsey, C. E., Wright, D., Colenso, C. K., Sessions, R. B., & Hancox, J. C. (2014). Assessing hERG pore models as templates for drug docking using published experimental constraints: The inactivated state in the context of drug block. Journal of Chemical Information and Modeling, 54(2), 601–612. https://doi.org/https://doi.org/10.1021/ci400707h
- Dickson, C. J., Velez-Vega, C., & Duca, J. S. (2020). Revealing molecular determinants of hERG blocker and activator binding. Journal of Chemical Information and Modeling, 60(1), 192–203. https://doi.org/https://doi.org/10.1021/acs.jcim.9b00773
- Durdagi, S., Subbotina, J., Lees-Miller, J., Guo, J., Duff, H. J., & Noskov, S. Y. (2010). Insights into the molecular mechanism of hERG1 channel activation and blockade by drugs. Current Medicinal Chemistry, 17(30), 3514–3532. https://doi.org/https://doi.org/10.2174/092986710792927886
- Eghbali, M., Olcese, R., Zarei, M. M., Toro, L., & Stefani, E. (2002). External pore collapse as an inactivation mechanism for Kv4.3 K + channels. The Journal of Membrane Biology, 188(1), 73–86. https://doi.org/https://doi.org/10.1007/s00232-001-0173-3
- Ficker, E., Jarolimek, W., Kiehn, J., Baumann, A., & Brown, A. M. (1998). Molecular determinants of dofetilide block of HERG K + channels. Circulation Research, 82(3), 386–395. https://doi.org/https://doi.org/10.1161/01.res.82.3.386
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Ghosh, A., Sonavane, U., Andhirka, S. K., Aradhyam, G. K., & Joshi, R. (2012). Structural insights into human GPCR protein OA1: A computational perspective. Journal of Molecular Modeling, 18(5), 2117–2133. https://doi.org/https://doi.org/10.1007/s00894-011-1228-8
- Hall, T. A. (1999). BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series, 41, 95–98.
- Helliwell, M. V., Zhang, Y., El Harchi, A., Du, C., Hancox, J. C., & Dempsey, C. E. (2018). Structural implications of hERG K + channel block by a high-affinity minimally structured blocker. The Journal of Biological Chemistry, 293(18), 7040–7057. https://doi.org/https://doi.org/10.1074/jbc.RA117.000363
- Hills, R. D., Jr., & McGlinchey, N. (2016). Model parameters for simulation of physiological lipids. Journal of Computational Chemistry, 37(12), 1112–1118. https://doi.org/https://doi.org/10.1002/jcc.24324
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD - Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38.
- Jiang, Y., Lee, A., Chen, J., Ruta, V., Cadene, M., Chait, B. T., & MacKinnon, R. (2003). X-ray structure of a voltage-dependent K + channel. Nature, 423(6935), 33–41. https://doi.org/https://doi.org/10.1038/nature01580
- Kalyaanamoorthy, S., & Barakat, K. H. (2018a). Binding modes of hERG blockers: An unsolved mystery in the drug design arena. Expert Opinion on Drug Discovery, 13(3), 207–210. https://doi.org/https://doi.org/10.1080/17460441.2018.1418319
- Kalyaanamoorthy, S., & Barakat, K. H. (2018b). Development of safe drugs: The hERG challenge. Medicinal Research Reviews, 38(2), 525–555. https://doi.org/https://doi.org/10.1002/med.21445
- Kandt, C., Ash, W. L., & Tieleman, D. P. (2007). Setting up and running molecular dynamics simulations of membrane proteins. Methods (San Diego, CA), 41(4), 475–488. https://doi.org/https://doi.org/10.1016/j.ymeth.2006.08.006
- Klauda, J. B., Venable, R. M., Freites, J. A., O’Connor, J. W., Tobias, D. J., Mondragon-Ramirez, C., Vorobyov, I., MacKerell, A. D., Jr., & Pastor, R. W. (2010). Update of the CHARMM all-atom additive force field for lipids: Validation on six lipid types. The Journal of Physical Chemistry B, 114(23), 7830–7843. https://doi.org/https://doi.org/10.1021/jp101759q
- Knape, K., Linder, T., Wolschann, P., Beyer, A., & Stary-Weinzinger, A. (2011). In silico analysis of conformational changes induced by mutation of aromatic binding residues: Consequences for drug binding in the hERG K + channel. PLoS One, 6(12), e28778. https://doi.org/https://doi.org/10.1371/journal.pone.0028778
- Köpfer, D. A., Hahn, U., Ohmert, I., Vriend, G., Pongs, O., de Groot, B. L., & Zachariae, U. (2012). A molecular switch driving inactivation in the cardiac K + channel HERG. PLoS One, 7(7), e41023. https://doi.org/https://doi.org/10.1371/journal.pone.0041023
- Kowal, J., Chami, M., Baumgartner, P., Arheit, M., Chiu, P. L., Rangl, M., Scheuring, S., Schröder, G. F., Nimigean, C. M., & Stahlberg, H. (2014). Ligand-induced structural changes in the cyclic nucleotide-modulated potassium channel MloK1. Nature Communications, 5, 3106. https://doi.org/https://doi.org/10.1038/ncomms4106
- Kumari, R., Kumar, R., Lynn, A., & Open Source Drug Discovery Consortium. (2014). g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
- Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK - a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/https://doi.org/10.1107/S0021889892009944
- Lee, W., Windley, M. J., Perry, M. D., Vandenberg, J. I., & Hill, A. P. (2019). Protocol-dependent differences in IC50 values measured in human ether-á-go-go-related gene assays occur in a predictable way and can be used to quantify state preference of drug binding. Molecular Pharmacology, 95(5), 537–550. https://doi.org/https://doi.org/10.1124/mol.118.115220
- Long, S. B., Campbell, E. B., & Mackinnon, R. (2005). Crystal structure of a mammalian voltage-dependent Shaker family K + channel. Science, 309(5736), 897–903. https://doi.org/https://doi.org/10.1126/science.1116269
- Long, S. B., Tao, X., Campbell, E. B., & MacKinnon, R. (2007). Atomic structure of a voltage-dependent K + channel in a lipid membrane-like environment. Nature, 450(7168), 376–382. https://doi.org/https://doi.org/10.1038/nature06265
- Massova, I., & Kollman, P. A. (2000). Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspectives in Drug Discovery and Design, 18(1), 113–135. https://doi.org/https://doi.org/10.1023/A:1008763014207
- Milnes, J. T., Witchel, H. J., Leaney, J. L., Leishman, D. J., & Hancox, J. C. (2010). Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide. Journal of Pharmacological and Toxicological Methods, 61(2), 178–191. https://doi.org/https://doi.org/10.1016/j.vascn.2010.02.007
- Mohammad, S., Zhou, Z., Gong, Q., & January, C. T. (1997). Blockage of the HERG human cardiac K + channel by the gastrointestinal prokinetic agent cisapride. American Journal of Physiology, 273(5), H2534–8. https://doi.org/https://doi.org/10.1152/ajpheart.1997.273.5.H2534
- Negami, T., Araki, M., Okuno, Y., & Terada, T. (2019). Calculation of absolute binding free energies between the hERG channel and structurally diverse drugs. Scientific Reports, 9(1), 16586. https://doi.org/https://doi.org/10.1038/s41598-019-53120-6
- Ng, C. A., Perry, M. D., Tan, P. S., Hill, A. P., Kuchel, P. W., & Vandenberg, J. I. (2012). The S4-S5 linker acts as a signal integrator for HERG K + channel activation and deactivation gating. PLoS One, 7(2), e31640. https://doi.org/https://doi.org/10.1371/journal.pone.0031640
- Orvos, P., Kohajda, Z., Szlovák, J., Gazdag, P., Árpádffy-Lovas, T., Tóth, D., Geramipour, A., Tálosi, L., Jost, N., Varró, A., & Virág, L. (2019). Evaluation of possible proarrhythmic potency: Comparison of the effect of dofetilide, cisapride, sotalol, terfenadine, and verapamil on hERG and native IKr currents and on cardiac action potential. Toxicological Sciences, 168(2), 365–380. https://doi.org/https://doi.org/10.1093/toxsci/kfy299
- Paissoni, C., Spiliotopoulos, D., Musco, G., & Spitaleri, A. (2015). GMXPBSA 2.1: A GROMACS tool to perform MM/PBSA and computational alanine scanning. Computer Physics Communications, 186(186), 105–107. https://doi.org/https://doi.org/10.1016/j.cpc.2014.09.010
- Perry, M. D., Ng, C. A., Mann, S. A., Sadrieh, A., Imtiaz, M., Hill, A. P., & Vandenberg, J. I. (2015). Getting to the heart of hERG K(+) channel gating. The Journal of Physiology, 593(12), 2575–2585. https://doi.org/https://doi.org/10.1113/JP270095
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084.
- Rampe, D., Roy, M. L., Dennis, A., & Brown, A. M. (1997). A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity blockade of the human cardiac potassium channel HERG. FEBS Letters, 417(1), 28–32. https://doi.org/https://doi.org/10.1016/s0014-5793(97)01249-0
- Roy, M., Dumaine, R., & Brown, A. M. (1996). HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation, 94(4), 817–823. https://doi.org/https://doi.org/10.1161/01.cir.94.4.817
- Saxena, P., Zangerl-Plessl, E. M., Linder, T., Windisch, A., Hohaus, A., Timin, E., Hering, S., & Stary-Weinzinger, A. (2016). New potential binding determinant for hERG channel inhibitors. Scientific Reports, 6, 24182. https://doi.org/https://doi.org/10.1038/srep24182
- Schmidtke, P., Ciantar, M., Theret, I., & Ducrot, P. (2014). Dynamics of hERG closure allow novel insights into hERG blocking by small molecules. Journal of Chemical Information and Modeling, 54(8), 2320–2333. https://doi.org/https://doi.org/10.1021/ci5001373
- Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., Thompson, J. D., & Higgins, D. G. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular Systems Biology, 7, 539. https://doi.org/https://doi.org/10.1038/msb.2011.75
- Skibinsky, A., Venable, R. M., & Pastor, R. W. (2005). A molecular dynamics study of the response of lipid bilayers and monolayers to trehalose. Biophysical Journal, 89(6), 4111–4121. https://doi.org/https://doi.org/10.1529/biophysj.105.065953
- Snyders, D. J., & Chaudhary, A. (1996). High affinity open channel block by dofetilide of HERG expressed in a human cell line. Molecular Pharmacology, 49(6), 949–955.
- Stary, A., Wacker, S. J., Boukharta, L., Zachariae, U., Karimi-Nejad, Y., Aqvist, J., Vriend, G., & de Groot, B. L. (2010). Toward a consensus model of the HERG potassium channel. ChemMedChem, 5(3), 455–467. https://doi.org/https://doi.org/10.1002/cmdc.200900461
- Stockbridge, N., Morganroth, J., Shah, R. R., & Garnett, C. (2013). Dealing with global safety issues: Was the response to QT-liability of non-cardiac drugs well coordinated? Drug Safety, 36(3), 167–182. https://doi.org/https://doi.org/10.1007/s40264-013-0016-z
- Tao, X., Lee, A., Limapichat, W., Dougherty, D. A., & MacKinnon, R. (2010). A gating charge transfer center in voltage sensors. Science (New York, NY), 328(5974), 67–73. https://doi.org/https://doi.org/10.1126/science.1185954
- van Aalten, D. M., Bywater, R., Findlay, J. B., Hendlich, M., Hooft, R. W., & Vriend, G. (1996). PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. Journal of Computer-Aided Molecular Design, 10(3), 255–262. https://doi.org/https://doi.org/10.1007/BF00355047
- Vandenberg, J. I., Perozo, E., & Allen, T. W. (2017). Towards a structural view of drug binding to hERG K + channels. Trends in Pharmacological Sciences, 38(10), 899–907. https://doi.org/https://doi.org/10.1016/j.tips.2017.06.004
- Vandenberg, J. I., Torres, A. M., Campbell, T. J., & Kuchel, P. W. (2004). The HERG K + channel: Progress in understanding the molecular basis of its unusual gating kinetics. European Biophysics Journal, 33(2), 89–97. https://doi.org/https://doi.org/10.1007/s00249-003-0338-3
- Wang, W., & MacKinnon, R. (2017). Cryo-EM structure of the open human Ether-à-go-go-related K + channel hERG. Cell, 169(3), 422–430. https://doi.org/https://doi.org/10.1016/j.cell.2017.03.048
- Webb, B., & Sali, A. (2016). Comparative Protein Structure Modeling Using MODELLER. Current Protocols in Bioinformatics, 54, 5.6.1–5.6.37. https://doi.org/https://doi.org/10.1002/cpbi.3
- Yan, M., Zhang, K., Shi, Y., Feng, L., Lv, L., & Li, B. (2015). Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency. Drug Design, Development and Therapy, 9, 5737–5747. https://doi.org/https://doi.org/10.2147/DDDT.S91561
- Yu, Z., IJzerman, A. P., & Heitman, L. H. (2015). Kv 11.1 (hERG)-induced cardiotoxicity: A molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors. British Journal of Pharmacology, 172(3), 940–955. https://doi.org/https://doi.org/10.1111/bph.12967